Products found to contain undeclared medicines
|
| |
| The United States: Green Lumber Holding, LLC issues consumer alert on counterfeit products following FDA findings |
| |
The United States Food and Drug Administration (FDA) announces that Green Lumber Holding, LLC (“Green Lumber”) is alerting consumers that counterfeit products misrepresented as genuine Green Lumber have been identified and may pose health risks.
This alert follows testing by the U.S. Food and Drug Administration (FDA), which detected tadalafil, an undeclared prescription drug, in products labeled as Green Lumber. Tadalafil is not an ingredient in any authentic Green Lumber product. Based on the FDA’s findings, Green Lumber conducted its own internal investigation and determined that a company employee diverted legitimate packaging and customer information to distribute counterfeit, adulterated product. That employee has since been terminated.
How to Identify Legitimate Green Lumber Product
Consumers should verify product authenticity by checking packaging details:
Authentic Green Lumber blister packs display Lot Number: LOTGLU13101b1EXP0926.
Counterfeit products do not show this lot number.
Packaging differences are illustrated in the news, please refer to the news in the FDA website for details.
Health Risks of Counterfeit Products
The counterfeit versions may contain undeclared tadalafil. Tadalafil is used in the management of erectile dysfunction. Because tadalafil is a prescription-only medication, individuals who take nitrates or certain prescription drugs for heart disease, blood pressure, or other conditions may be at risk of life-threatening side effects such as dangerously low blood pressure or other serious adverse events.
Please refer to the following website in FDA for details:
http://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/green-lumber-holding-llc-issues-consumer-alert-counterfeit-products-following-fda-findings
In Hong Kong, the above product is not a registered pharmaceutical product. Related news was previously issued by FDA, and was posted on the Drug Office website on 21 Sep 2019, 24 Oct 2019 and 16 Aug 2025.
Ends/Saturday, 30 Aug, 2025
Issued at HKT 12:00
|
| |
|
